162 related articles for article (PubMed ID: 22168830)
1. Protective effect of cardioplegia with poly (ADP-ribose) polymerase-1 inhibitor against myocardial ischemia-reperfusion injury: in vitro study of isolated rat heart model.
Yamazaki K; Tanaka S; Sakata R; Miwa S; Oriyanhan W; Takaba K; Minakata K; Marui A; Ikeda T; Toyokuni S; Komeda M; Ueda K
J Enzyme Inhib Med Chem; 2013 Feb; 28(1):143-7. PubMed ID: 22168830
[TBL] [Abstract][Full Text] [Related]
2. Prevention of myocardial reperfusion injury by poly(ADP-ribose) synthetase inhibitor, 3-aminobenzamide, in cardioplegic solution: in vitro study of isolated rat heart model.
Yamazaki K; Miwa S; Ueda K; Tanaka S; Toyokuni S; Unimonh O; Nishimura K; Komeda M
Eur J Cardiothorac Surg; 2004 Aug; 26(2):270-5. PubMed ID: 15296882
[TBL] [Abstract][Full Text] [Related]
3. Caffeic acid phenethyl ester (CAPE) supplemented St. Thomas' hospital cardioplegic solution improves the antioxidant defense system of rat myocardium during ischemia-reperfusion injury.
Ozeren M; Sucu N; Tamer L; Aytacoglu B; Bayri O; Döndaş A; Ayaz L; Dikmengil M
Pharmacol Res; 2005 Sep; 52(3):258-63. PubMed ID: 15890527
[TBL] [Abstract][Full Text] [Related]
4. Effect of edaravone, a novel free radical scavenger, supplemented to cardioplegia on myocardial function after cardioplegic arrest: in vitro study of isolated rat heart.
Yamazaki K; Miwa S; Toyokuni S; Nemoto S; Oriyanhan W; Takaba K; Saji Y; Marui A; Nishina T; Ikeda T; Komeda M
Heart Vessels; 2009 May; 24(3):228-35. PubMed ID: 19466525
[TBL] [Abstract][Full Text] [Related]
5. The protective effect of St. Thomas cardioplegia enriched with zacopride on the isolated rat heart.
Wu B; Long C; Hei F; Wang S
Artif Organs; 2013 Jan; 37(1):E44-50. PubMed ID: 23067559
[TBL] [Abstract][Full Text] [Related]
6. Cardioprotection with esmolol cardioplegia: efficacy as a blood-based solution.
Fujii M; Chambers DJ
Eur J Cardiothorac Surg; 2013 Mar; 43(3):619-27. PubMed ID: 22715477
[TBL] [Abstract][Full Text] [Related]
7. Critical role of PI3-kinase/Akt activation in the PARP inhibitor induced heart function recovery during ischemia-reperfusion.
Kovacs K; Toth A; Deres P; Kalai T; Hideg K; Gallyas F; Sumegi B
Biochem Pharmacol; 2006 Feb; 71(4):441-52. PubMed ID: 16337154
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of poly(adp-ribose) polymerase reduces cardiomyocytic apoptosis after global cardiac arrest under cardiopulmonary bypass.
Yeh CH; Chen TP; Lee CH; Wu YC; Lin YM; Jing Lin P
Shock; 2006 Feb; 25(2):168-75. PubMed ID: 16525356
[TBL] [Abstract][Full Text] [Related]
9. Cardioprotective effects of low-dose cyclosporin A added to histidine-tryptophan-ketoglutarate cardioplegia solution prior to total myocardial ischemia: an in vitro rabbit heart study.
Pritzwald-Stegmann P; Hoyer A; Kempfert J; Dhein S; Mohr FW
Pharmacology; 2011; 88(3-4):167-73. PubMed ID: 21952163
[TBL] [Abstract][Full Text] [Related]
10. Myocardial protection: the efficacy of an ultra-short-acting beta-blocker, esmolol, as a cardioplegic agent.
Bessho R; Chambers DJ
J Thorac Cardiovasc Surg; 2001 Nov; 122(5):993-1003. PubMed ID: 11689806
[TBL] [Abstract][Full Text] [Related]
11. Poly(ADP-ribose) polymerase inhibition improves postischemic myocardial function after cardioplegia-cardiopulmonary bypass.
Khan TA; Ruel M; Bianchi C; Voisine P; Komjáti K; Szabo C; Sellke FW
J Am Coll Surg; 2003 Aug; 197(2):270-7. PubMed ID: 12892811
[TBL] [Abstract][Full Text] [Related]
12. Effect of poly(ADP-ribose) polymerase inhibitors on the ischemia-reperfusion-induced oxidative cell damage and mitochondrial metabolism in Langendorff heart perfusion system.
Halmosi R; Berente Z; Osz E; Toth K; Literati-Nagy P; Sumegi B
Mol Pharmacol; 2001 Jun; 59(6):1497-505. PubMed ID: 11353811
[TBL] [Abstract][Full Text] [Related]
13. Protection from reperfusion injury after cardiac transplantation by inhibition of adenosine metabolism and nucleotide precursor supply.
Smolenski RT; Raisky O; Slominska EM; Abunasra H; Kalsi KK; Jayakumar J; Suzuki K; Yacoub MH
Circulation; 2001 Sep; 104(12 Suppl 1):I246-52. PubMed ID: 11568064
[TBL] [Abstract][Full Text] [Related]
14. Continuous inhibition of poly(ADP-ribose) polymerase does not reduce reperfusion injury in isolated rat heart.
Nishizawa K; Yanagida S; Yamagishi T; Takayama E; Bessho M; Kusuhara M; Adachi T; Ohsuzu F
J Cardiovasc Pharmacol; 2013 Jul; 62(1):99-105. PubMed ID: 23846805
[TBL] [Abstract][Full Text] [Related]
15. [Effect of CoQ10 on myocardial ischemia/reperfusion injury in the isolated rat heart].
Yamamoto H; Yamamoto F
Nihon Kyobu Geka Gakkai Zasshi; 1995 Apr; 43(4):466-72. PubMed ID: 7608595
[TBL] [Abstract][Full Text] [Related]
16. Inhibitors of poly (ADP-ribose) polymerase ameliorate myocardial reperfusion injury by modulation of activator protein-1 and neutrophil infiltration.
Kaplan J; O'Connor M; Hake PW; Zingarelli B
Shock; 2005 Mar; 23(3):233-8. PubMed ID: 15718920
[TBL] [Abstract][Full Text] [Related]
17. [The effect of different dose of verapamil and propranolol in kalium cardioplegia on the function of immature rat heart].
Fang QJ; Wang YF; Wang RX; Wu ZJ; He RL; Peng XP
Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2008 May; 24(2):170-4. PubMed ID: 21141518
[TBL] [Abstract][Full Text] [Related]
18. Role of sodium pump activity in warm induction of cardioplegia combined with reperfusion of oxygenated cardioplegic solution.
Ko T; Otani H; Imamura H; Omori K; Inagaki C
J Thorac Cardiovasc Surg; 1995 Jul; 110(1):103-10. PubMed ID: 7609533
[TBL] [Abstract][Full Text] [Related]
19. A novel and orally active poly(ADP-ribose) polymerase inhibitor, KR-33889 [2-[methoxycarbonyl(4-methoxyphenyl) methylsulfanyl]-1H-benzimidazole-4-carboxylic acid amide], attenuates injury in in vitro model of cell death and in vivo model of cardiac ischemia.
Oh KS; Lee S; Yi KY; Seo HW; Koo HN; Lee BH
J Pharmacol Exp Ther; 2009 Jan; 328(1):10-8. PubMed ID: 18836068
[TBL] [Abstract][Full Text] [Related]
20. [Cardioprotective effects of cariporide as an adjunct in different cardioplegic solutions: an experiment with rabbits].
Zhou RH; Long C; Liu J; Liu B
Zhonghua Yi Xue Za Zhi; 2007 Sep; 87(33):2320-3. PubMed ID: 18036293
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
